A Melander
Overview
Explore the profile of A Melander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
258
Citations
2425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tyrberg M, Lindblad U, Melander A, Lovestam-Adrian M, Ponjavic V, Andreasson S
Doc Ophthalmol
. 2011 Nov;
123(3):193-8.
PMID: 22057379
The purpose of this study was to investigate the early alterations of retinal function, assessed with electrophysiology, in newly onset type 2 diabetes patients without vascular retinopathy. Seventeen patients with...
2.
Lindblad U, Lindberg G, Mansson N, Ranstam J, Tyrberg M, Jansson S, et al.
Diabetes Obes Metab
. 2011 Jan;
13(2):185-8.
PMID: 21199271
The Nepi ANtidiabetes StudY (NANSY) is a 5-year randomized, double-blind, placebo-controlled trial in Swedish primary care, examining whether the development of type 2 diabetes (T2D) and retinopathy (separately reported) would...
3.
Lindberg G, Olsson J, Melander A
Pharmacoepidemiol Drug Saf
. 2008 Nov;
9(2):127-31.
PMID: 19025812
Objectives: In previous trials, patients with type 2 diabetes using calcium channel blockers (CCB) have suffered a less favourable outcome when compared with patients on other treatments. The present study...
4.
Tyrberg M, Melander A, Lovestam-Adrian M, Lindblad U
Diabetes Obes Metab
. 2007 Jul;
10(8):646-51.
PMID: 17645554
Aims: Network for Pharmacoepidemiology (NEPI) Antidiabetes Study-Eye is a randomized placebo-controlled Swedish trial investigating if treatment with sulphonylurea, in addition to dietary regulation and increased exercise, delays the development of...
5.
Melander A, Folino-Gallo P, Walley T, Schwabe U, Groop P, Klaukka T, et al.
Diabetologia
. 2006 Jul;
49(9):2024-9.
PMID: 16865360
Aims/hypothesis: The aim of this study was to compare developments in the utilisation of antihyperglycaemic drugs (AHGDs) in ten European countries. Subjects And Methods: Data on the yearly utilisation of...
6.
Ohlsson H, Lindblad U, Lithman T, Ericsson B, Gerdtham U, Melander A, et al.
Eur J Clin Pharmacol
. 2005 Sep;
61(9):657-65.
PMID: 16133551
Objective: The aim was to investigate the role that municipalities and out-patient health care centres (HCCs) have in understanding adherence to official guidelines on statin prescribing. Our hypothesis was that...
7.
Hellgren M, Melander A, Ostgren C, Rastam L, Lindblad U
Diabetes Obes Metab
. 2005 Jun;
7(4):421-9.
PMID: 15955129
Aim: This study aimed to investigate levels of Homocysteine (tHcy) and folate in a population-based sample of patients with type 2 diabetes. In particular, the study explored modifiable determinants such...
8.
Henricson K, Stenberg P, Rametsteiner G, Ranstam J, Hanson B, Melander A
Pharmacoepidemiol Drug Saf
. 2004 Apr;
7(4):261-7.
PMID: 15073988
The aim of the present study was to elucidate the relations between demographic and socioeconomic factors, morbidity and the utilization of major drug groups in an urban Swedish population. The...
9.
Bog-Hansen E, Lindblad U, Gullberg B, Melander A, Rastam L
Diabetes Obes Metab
. 2003 Nov;
5(6):379-87.
PMID: 14617223
Aim: To examine the prevalence and characteristics of uncontrolled hypertension (HT). Methods: A cross-sectional community-based study (1992-93) was carried out in Skara, Sweden, including 894 patients who consecutively underwent an...
10.
Hermann L, Lindberg G, Lindblad U, Melander A
Diabetes Obes Metab
. 2002 Aug;
4(5):296-304.
PMID: 12190992
No abstract available.